Market Place
Sourcing Support
Twist Bioscience reports robust Q4 with revenue up 27%
19 Nov 2024 //
INVESTING
Twist Bioscience Announces Inducement Grants Under NASDAQ Rule 5635
07 Nov 2024 //
BUSINESSWIRE
XOMA Royalty Q3 2024 Results & Recent Activities
07 Nov 2024 //
GLOBENEWSWIRE
Twist Bioscience To Report Q4 2024 Results On Nov 18
24 Oct 2024 //
BUSINESSWIRE
Twist Bioscience Enters Royalty Purchase Agreement For $15M
22 Oct 2024 //
BUSINESSWIRE
XOMA Royalty Expands Portfolio With 60 Programs From Twist
22 Oct 2024 //
GLOBENEWSWIRE
Twist Bioscience Appoints Mike Fero, Ph.D as CIO
15 Oct 2024 //
BUSINESSWIRE
Twist partners with MedGenome in India to diagnose rare diseases
26 Sep 2024 //
FINANCIALXPRESS
Twist Bioscience Issues 2024 Corporate Responsibility Report
09 Sep 2024 //
BUSINESSWIRE
Twist Bioscience And bitBiome Collaborate On Biocatalysis Enzymes
05 Aug 2024 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
02 Aug 2024 //
BUSINESSWIRE
Twist`s Antibody Libraries Aid Pure Biologics` Clinical Candidate
18 Jul 2024 //
BUSINESSWIRE
Twist Bioscience To Report Fiscal 2024 Third Quarter Results On August 2
11 Jul 2024 //
BUSINESSWIRE
Twist Bioscience Launches CHO Express Antibodies For IgG Portfolio
10 Jul 2024 //
BUSINESSWIRE
Twist Bioscience joins with US AI Safety Institute Consortium to support devep
06 Jun 2024 //
PHARMABIZ
ONT, Twist Bio Launch Pharmacogenomics Program
22 May 2024 //
BUSINESSWIRE
Twist Bioscience Corporation: Inducement Grants Announcement
08 May 2024 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
02 May 2024 //
BUSINESSWIRE
Twist Bio To Report Fiscal Q2 2024 Results On May 2
18 Apr 2024 //
BUSINESSWIRE
Twist Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
05 Mar 2024 //
BUSINESSWIRE
Twist Bioscience to Present at Upcoming Investor Conferences
22 Feb 2024 //
BUSINESSWIRE
Twist Bio Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
07 Feb 2024 //
BUSINESSWIRE
Twist Bio and Element Bio Collaborate on Exome Sequencing Solutions
06 Feb 2024 //
PRESS RELEASE
Twist Bio Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
06 Feb 2024 //
BUSINESSWIRE
Twist Bio Unveils Differentiated Ultra High-Throughput Library Solution
05 Feb 2024 //
PRESS RELEASE
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
02 Feb 2024 //
PRESS RELEASE
Twist Bioscience Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
08 Jan 2024 //
BUSINESSWIRE
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
18 Dec 2023 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal Fourth Quarter
17 Nov 2023 //
BUSINESSWIRE
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
13 Nov 2023 //
BUSINESSWIRE
Twist Bio Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08 Nov 2023 //
BUSINESSWIRE
Twist to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results
02 Nov 2023 //
BUSINESSWIRE
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
03 Oct 2023 //
BUSINESSWIRE
Twist Bioscience Enters into Agreement with Ono to Discover Novel Antibodies
31 Aug 2023 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
04 Aug 2023 //
BUSINESSWIRE
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results
20 Jul 2023 //
BUSINESSWIRE
Twist Bio & Cancer Research Horizons Enter into Collaboration for Cancer Research
18 Jul 2023 //
BUSINESSWIRE
Twist Bioscience Appoints Chet Gandhi as CI Officer
20 Jun 2023 //
BUSINESSWIRE
Twist Bioscience lays off 212 staffers, mostly in San Francisco
17 Jun 2023 //
ENDPTS
Twist trims workforce by 25% amid record-high revenues
08 May 2023 //
FIERCE BIOTECH
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
05 May 2023 //
BUSINESSWIRE
Twist Bioscience Enters into Third Collaboration with Astellas
20 Apr 2023 //
BUSINESSWIRE
Twist Announces Robust Antibody Discovery Services Integrating In Vivo
09 Mar 2023 //
BUSINESSWIRE
Sampled Named a “Next-Generation Sequencing ProLab” for Twist Bioscience
07 Mar 2023 //
BUSINESSWIRE
Twist Bioscience Publishes Data on VHH Single Domain Antibody Discovery
14 Feb 2023 //
BUSINESSWIRE
Twist Announces Early Access of Enhanced Whole Genome Sequencing Solution
07 Feb 2023 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
03 Feb 2023 //
BUSINESSWIRE
Twist Begins Shipping Product from Synthetic DNA Manufacturing Factory
26 Jan 2023 //
BUSINESSWIRE
Twist Bioscience to Report Fiscal 2023 Q1 Financial Results on February 3, 2023
19 Jan 2023 //
BUSINESSWIRE
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease
10 Jan 2023 //
BUSINESSWIRE
Twist Bioscience and Astellas Enter into Antibody Discovery Collaboration
09 Jan 2023 //
BUSINESSWIRE
Astellas` intergalactic quest finds 2 pacts with Twist, Selecta
09 Jan 2023 //
FIERCE BIOTECH
Twist’s `factory of the future` in Oregon could deliver with competitive pricing
30 Nov 2022 //
ENDPTS
Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference
23 Nov 2022 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal 4Q and Full Year Fiscal 2022 Financial Results
18 Nov 2022 //
BUSINESSWIRE
Twist Bioscience Addresses Misleading Short-Seller Report
15 Nov 2022 //
BUSINESSWIRE
Twist Bio to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results
03 Nov 2022 //
BUSINESSWIRE
Twist Bioscience to Present at JSNN NanoImpacts 2022
05 Oct 2022 //
BUSINESSWIRE
ARC CoESB and Twist Bioscience Partner to Accelerate Synthetic Biology Research
20 Sep 2022 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
05 Aug 2022 //
PRESS RELEASE
